Human pharmacokinetics of N-L-leucyl-doxorubicin, a new anthracycline derivative, and its correlation with clinical toxicities.

Canal, P; Robert, J; Ramon, M; Baurain, R; Tresca, P; de Forni, M; Marty, M; Pujade-Lauraine, E; Bugat, R; Magis, A

Canal, P; Robert, J; Ramon, M; Baurain, R; Tresca, P; de Forni, M; Marty, M; Pujade-Lauraine, E; Bugat, R; Magis, A.

Affiliation

Canal P; Centre Claudius Regaud, Toulouse, France.

Clin Pharmacol Ther ; 51(3): 249-59, 1992 Mar.

Article in En | MEDLINE | ID: mdl-1544285

Subject(s)

Doxorubicin/analogs & derivatives; Dose-Response Relationship, Drug; Doxorubicin/administration & dosage; Doxorubicin/adverse effects; Doxorubicin/blood; Doxorubicin/pharmacokinetics; Drug Evaluation; Humans; Leukocyte Count/drug effects; Platelet Count/drug effects; Regression Analysis; Stomatitis/chemically induced

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 1992 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links